Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 86
Selected: 0
NCT IDTitle
NCT06686745Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
NCT04830644A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
NCT05569057A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
NCT01368419Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
NCT07345364A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
NCT01109264Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia
NCT05665647Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants
NCT06010693A Study of Daridorexant in Chinese Patients With Insomnia Disorder
NCT06331559Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
NCT04902885Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients
NCT05071703Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study
NCT05369676To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
NCT02650375Study of Metatinib Tromethamine Tablet
NCT05148195A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
NCT06326723Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects
NCT06375044Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
NCT06680921A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
NCT03588494Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
NCT04908787A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer
NCT07050459A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT02275299Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
NCT03424928A Pilot Bioequivalence Study of Pomalidomide
NCT05718219Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors
NCT03577392Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
NCT07357610An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
NCT05200728The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers
NCT05731804Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir
NCT01531790A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
NCT02375022Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
NCT04440436Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients
NCT02722694A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT07266493Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT05506176A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
NCT02453464A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer
NCT05339646A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects
NCT01929096Compound Edaravone Injection for Acute Ischemic Stroke
NCT05781386A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
NCT02652234Study of Endostar Subcutaneous Injection in NSCLC
NCT05885919Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
NCT06698965Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
NCT07348211First in Human Study of SIM0610 in Solid Tumors
NCT05528055A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors
NCT01909856The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
NCT04914598A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
NCT01772732Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC
NCT05826249Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects
NCT04942301PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
NCT05254665A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors
NCT06022354To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
NCT04671849An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.